The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.

Investors need to pay close attention to Hologic (HOLX) stock based on the movements in the options market lately.

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Shares of Hologic Inc. HOLX slipped 1.46% to $63.53 Wednesday, on what proved to be an all-around rough trading session for ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted ...

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

It's been a mediocre week for Hologic, Inc. ( NASDAQ:HOLX ) shareholders, with the stock dropping 10% to US$64.58 ...

Louisiana State Employees Retirement System decreased its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent 13F filing with ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday.